Global CRO Pharm-Olam International Ltd. Announces New Addition To The Quality And Compliance Leadership Team
HOUSTON--(BUSINESS WIRE)--Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced the appointment of Daniel Burgess to the position of Senior Director, Quality and Compliance.
“In clinical trials, Quality Assurance and Compliance considerations go hand-in-hand,” said Sanjiv Suri, Chief Executive Officer, Pharm-Olam.
“In clinical trials, Quality Assurance and Compliance considerations go hand-in-hand,” said Sanjiv Suri, Chief Executive Officer, Pharm-Olam.